Please use this identifier to cite or link to this item:
Scopus Web of Science® Altmetric
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPohle, K.-
dc.contributor.authorDomschke, K.-
dc.contributor.authorRoehrs, T.-
dc.contributor.authorArolt, V.-
dc.contributor.authorBaune, B.-
dc.identifier.citationPsychotherapy and Psychosomatics, 2009; 78(6):359-363-
dc.description.abstract<h4>Background</h4>This study aimed at the impact of medical comorbidity (MC) on response to antidepressant treatment over 6 weeks in diagnostic subtypes of patients with major depressive episode (MDE).<h4>Methods</h4>In a clinical sample of 241 admitted patients with MDE, MC was assessed by medical specialists and weekly response to antidepressant treatment was assessed with the Hamilton Depression Scale (HAM-D 21).<h4>Results</h4>Over 6 weeks of treatment, patients with melancholic depression and MC had poorer treatment response on the HAM-D scale and a worse functional outcome (GAF) as opposed to their counterparts without MC, which was first detected after 4 weeks of treatment (p = 0.02). More specifically, subjects with melancholic depression and cardiovascular or endocrinological MC showed significantly poorer treatment response over 6 weeks. Interestingly, these effects were not related to various antidepressant treatment regimens.<h4>Conclusions</h4>MC has a negative impact on treatment response in patients with melancholic depression.-
dc.description.statementofresponsibilityK. Pohle, K. Domschke, T. Roehrs, V. Arolt, B.T. Baune-
dc.rights© 2009 S. Karger AG, Basel-
dc.subjectMedical comorbidity-
dc.subjectSubtypes of depression-
dc.subjectTreatment response-
dc.titleMedical Comorbidity Affects Antidepressant Treatment Response in Patients with Melancholic Depression-
dc.typeJournal article-
dc.identifier.orcidBaune, B. [0000-0001-6548-426X]-
Appears in Collections:Aurora harvest
Psychiatry publications

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.